Pre-Exposure Prophylaxis With TDF/FTC to Prevent HIV-1 Acquisition in Young Men and Transgender Women of Color Who Have Sex With Men
Phase of Trial: Phase II
Latest Information Update: 14 Oct 2016
At a glance
- Drugs Emtricitabine (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 10 Oct 2016 Status changed from active, no longer recruiting to completed.
- 10 Aug 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
- 27 Feb 2015 New trial record